Brief: Stoke Therapeutics Inc - Cash Runway Anticipated To Fund Operations Into 2025
10/05/2022 12:18
May 10 (Reuters) - Stoke Therapeutics Inc STOK.O :
* STOKE THERAPEUTICS INC - CASH RUNWAY ANTICIPATED TO FUND
OPERATIONS INTO 2025
* STOKE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.66
Source text for Eikon: [https://bit.ly/37BDsCI]
Further company coverage: STOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stoke Therapeutics
See all newsBrief: Stoke Therapeutics Announces Inducement Grants
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare
U.S. STOCKS ON THE MOVE-NetEase, Werewolf Therapeutics, JP Morgan
U.S. STOCKS ON THE MOVE-Ubiquiti, BJ's Wholesale, Arbutus
U.S. STOCKS ON THE MOVE-Gold miners, Ross Stores, Stoke Therapeutics